These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22998042)

  • 21. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.
    DeVane CL; Stowe ZN; Donovan JL; Newport DJ; Pennell PB; Ritchie JC; Owens MJ; Wang JS
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):54-9. PubMed ID: 16785271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss HL; Laux G; Müller-Oerlingenhausen B; Rao ML; Riederer P; Zernig G; ;
    Rev Med Suisse; 2006 May; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence.
    van Hasselt FM; Coehorst Y; Wilffert B; Loonen AJ
    Pharmacopsychiatry; 2013 Mar; 46(2):43-6. PubMed ID: 23037948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphic cytochromes P450 and drugs used in psychiatry.
    Coutts RT; Urichuk LJ
    Cell Mol Neurobiol; 1999 Jun; 19(3):325-54. PubMed ID: 10319191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology.
    Hiemke C
    Curr Drug Deliv; 2016; 13(3):353-61. PubMed ID: 26511090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges.
    Hiemke C
    Ther Drug Monit; 2019 Apr; 41(2):174-179. PubMed ID: 30883511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic drug monitoring of psychotropic medications.
    Mitchell PB
    Br J Clin Pharmacol; 2001; 52 Suppl 1(Suppl 1):45S-54S. PubMed ID: 11564052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring in child and adolescent psychiatry.
    Egberts KM; Mehler-Wex C; Gerlach M
    Pharmacopsychiatry; 2011 Sep; 44(6):249-53. PubMed ID: 21959786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic drug monitoring. Principles and practice.
    Preskorn SH; Burke MJ; Fast GA
    Psychiatr Clin North Am; 1993 Sep; 16(3):611-45. PubMed ID: 8415237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs.
    Stingl J; Viviani R
    J Intern Med; 2015 Feb; 277(2):167-177. PubMed ID: 25297512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
    Dahl ML
    Clin Pharmacokinet; 2002; 41(7):453-70. PubMed ID: 12083975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotyping and phenotyping the cytochrome p-450 enzymes.
    Bachmann KA
    Am J Ther; 2002; 9(4):309-16. PubMed ID: 12115020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
    Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
    Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol.
    Lisbeth P; Vincent H; Kristof M; Bernard S; Manuel M; Hugo N
    Eur J Clin Pharmacol; 2016 Feb; 72(2):175-84. PubMed ID: 26514968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
    de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
    OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics of antidepressants: clinical aspects.
    Bertilsson L; Dahl ML; Tybring G
    Acta Psychiatr Scand Suppl; 1997; 391():14-21. PubMed ID: 9265947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic drug monitoring in Italian psychiatry.
    Conca A; Schmidt E; Pastore M; Hiemke C; Duffy D; Giupponi G
    Pharmacopsychiatry; 2011 Sep; 44(6):259-62. PubMed ID: 21959788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study.
    Tamminga WJ; Wemer J; Oosterhuis B; de Boer A; Vranckx S; Drenth BF; de Zeeuw RA; de Leij LF; Jonkman JH
    Eur J Clin Pharmacol; 2003 May; 59(1):57-64. PubMed ID: 12743673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes (PBLs).
    Kuhlmann JB; Wensing G; Kuhlmann J
    Int J Clin Pharmacol Ther; 2014 Feb; 52(2):143-50. PubMed ID: 24361088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Availability of CYP2D6 genotyping results in general practitioner and community pharmacy medical records.
    Simoons M; Mulder H; Schoevers RA; Ruhé HG; van Roon EN
    Pharmacogenomics; 2017 Jun; 18(9):843-851. PubMed ID: 28594282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.